Jennison Associates LLC Pacific Biosciences Of California, Inc. Transaction History

Jennison Associates LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 03, 2023	SELL	$9.97 - $14.05 $175,272 - $246,999	-17,580 Reduced 22.83%	59,408 $790,000
Q1 2023 Apr 26, 2023	SELL	$7.94 - $12.02 $13,498 - $20,434	-1,700 Reduced 2.16%	76,988 $891,000
Q4 2022 Feb 09, 2023	SELL	$5.67 - $11.2 $559,084 - $1.1 Million	-98,604 Reduced 55.62%	78,688 $643,000
Q3 2022 Nov 01, 2022	BUY	$3.93 - $8.57 $94,819 - $206,768	24,127 Added 15.75%	177,292 $1.03 Million
Q2 2022 Aug 02, 2022	BUY	$4.02 - $10.43 $285,214 - $739,998	70,949 Added 86.3%	153,165 $677,000
Q1 2022 May 11, 2022	BUY	$8.43 - $20.9 $693,080 - $1.72 Million	82,216 New	82,216 $748,000

254

228M

745K

1.23M

Ticker PACB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 224,840,992
Market Cap $438M
Description
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...

Get notified when there are updates to the investment portfolio of Jennison Associates LLC, based on Form 13F filings with the SEC.

Stay updated on Jennison Associates LLC with notifications on news.